148 related articles for article (PubMed ID: 17401744)
1. Gadolinium encephalopathy due to accidental intrathecal administration of gadopentetate dimeglumine.
Arlt S; Cepek L; Rustenbeck HH; Prange H; Reimers CD
J Neurol; 2007 Jun; 254(6):810-2. PubMed ID: 17401744
[No Abstract] [Full Text] [Related]
2. Neurotoxic manifestations of an overdose intrathecal injection of gadopentetate dimeglumine.
Park KW; Im SB; Kim BT; Hwang SC; Park JS; Shin WH
J Korean Med Sci; 2010 Mar; 25(3):505-8. PubMed ID: 20191058
[TBL] [Abstract][Full Text] [Related]
3. Overdosage of intrathecal gadolinium and neurological response.
Li L; Gao FQ; Zhang B; Luo BN; Yang ZY; Zhao J
Clin Radiol; 2008 Sep; 63(9):1063-8. PubMed ID: 18718238
[No Abstract] [Full Text] [Related]
4. Intrathecal gadolinium (gadopentetate dimeglumine) enhanced magnetic resonance myelography and cisternography: results of a multicenter study.
Tali ET; Ercan N; Krumina G; Rudwan M; Mironov A; Zeng QY; Jinkins JR
Invest Radiol; 2002 Mar; 37(3):152-9. PubMed ID: 11882795
[TBL] [Abstract][Full Text] [Related]
5. Complex imaging features of accidental cerebral intraventricular gadolinium administration.
Nayak NB; Huang JC; Hathout GM; Shaba W; El-Saden SM
J Neurosurg; 2013 May; 118(5):1130-4. PubMed ID: 23495884
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal gadolinium-enhanced MR myelography and cisternography: a pilot study in human patients.
Zeng Q; Xiong L; Jinkins JR; Fan Z; Liu Z
AJR Am J Roentgenol; 1999 Oct; 173(4):1109-15. PubMed ID: 10511188
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal administration of gadopentetate dimeglumine for MR cisternography of nasoethmoidal CSF fistula.
Arbeláez A; Medina E; Rodríguez M; Londoño AC; Castillo M
AJR Am J Roentgenol; 2007 Jun; 188(6):W560-4. PubMed ID: 17515349
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal gadolinium-enhanced MR cisternography in the evaluation of clinically suspected cerebrospinal fluid rhinorrhea in humans: early experience.
Jinkins JR; Rudwan M; Krumina G; Tali ET
Radiology; 2002 Feb; 222(2):555-9. PubMed ID: 11818627
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance characteristics and susceptibility weighted imaging of the brain in gadolinium encephalopathy.
Samardzic D; Thamburaj K
J Neuroimaging; 2015; 25(1):136-9. PubMed ID: 24251880
[TBL] [Abstract][Full Text] [Related]
10. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
[TBL] [Abstract][Full Text] [Related]
11. Contrast-induced encephalopathy presenting as acute subarachnoid hemorrhage.
Pokersnik JA; Liu L; Simon EL
Am J Emerg Med; 2018 Jun; 36(6):1122.e3-1122.e4. PubMed ID: 29636294
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
Cheong BY; Duran C; Preventza OA; Muthupillai R
AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced MR cisternography used to determine potential communication between the cerebrospinal fluid pathways and intracranial arachnoid cysts.
Tali ET; Ercan N; Kaymaz M; Pasaoglu A; Jinkins JR
Neuroradiology; 2004 Sep; 46(9):744-54. PubMed ID: 15289956
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Fenestra VC Contrast-enhanced computed tomography imaging with gadopentetate dimeglumine and ferucarbotran magnetic resonance imaging for the in vivo evaluation of murine liver damage after ischemia and reperfusion.
Choukèr A; Lizak M; Schimel D; Helmberger T; Ward JM; Despres D; Kaufmann I; Bruns C; Löhe F; Ohta A; Sitkovsky MV; Klaunberg B; Thiel M
Invest Radiol; 2008 Feb; 43(2):77-91. PubMed ID: 18197060
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: case series of 36 patients.
Abujudeh HH; Kaewlai R; Kagan A; Chibnik LB; Nazarian RM; High WA; Kay J
Radiology; 2009 Oct; 253(1):81-9. PubMed ID: 19709997
[TBL] [Abstract][Full Text] [Related]
17. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.
Durmus T; Schilling R; Doeblin P; Huppertz A; Hamm B; Taupitz M; Wagner M
Invest Radiol; 2012 Mar; 47(3):183-8. PubMed ID: 22183078
[TBL] [Abstract][Full Text] [Related]
18. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
19. Extensive cerebrospinal fluid enhancement with gadopentetate dimeglumine in a primitive neuroectodermal tumor.
Naul LG; Finkenstaedt M
AJNR Am J Neuroradiol; 1997 Oct; 18(9):1709-11. PubMed ID: 9367319
[TBL] [Abstract][Full Text] [Related]
20. Incidence of immediate gadolinium contrast media reactions.
Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
